Documente Academic
Documente Profesional
Documente Cultură
Daniela Lazăr1,Ioan Sporea1, Denisia Tornea1, Liliana Girboni1, Cristina Filip1, Virgil
Ardelean1, Raluca Lupuşoru1, Ioan Romoşan2, Adrian Goldiş1
Introducere: Scopul studiului a constat în analiza acurateţei a trei scoruri de risc utilizate în
hemoragia digestivă superioară non-variceală (HDS-NV) ca evaluare a prognosticului
pacienţilor, estimate anterior ca fiind predictive pentru resângerare/deces după un episod de
sângerare gastrointestinală.
Material şi metodă: Am evaluat retrospectiv un lot de 1872 pacienţi internaţi în Clinica de
Gastroenterologie a Spitalului Clinic Judeţean de Urgenţă Timişoara cu HDS-NV într-o
perioadă de 12 ani, la care am calculat 3 scoruri de risc, Rockall, Cedars-Sinai şi Baylor. Am
comparat acurateţea acestora în evaluarea prognosticului pacienţilor, exprimat ca necesar de
transfuzii de sânge, număr zile spitalizare, resângerare, transfer în chirurgie şi deces.
Capacitatea discriminativă a fost evaluată utilizând aria de sub curba ROC (AUROC).
Rezultate şi concluzii: Lotul a inclus 1134 (60.6%) bărbaţi şi 738 (39.4%) femei, vârsta
medie fiind de 627.8 ani. În ceea ce priveşte necesarul de transfuzii de sânge, capacitatea
predictivă a scorurilor este după cum urmează:Rockall AUROC 0.59,
sensibilitate(Se)=81.7%, specificitate(Sp)=35.5%, valoare predictivă pozitivă (PPV)=28.4%,
valoare predictivă negativă(NPV)=86.1%;Cedars-Sinai AUROC 0.59, Se=72.4%, Sp=41.3%,
PPV=28.5%, NPV=82.3%;Baylor AUROC 0.56, Se=41.9%, Sp=75.5%, PPV=40.6%,
NPV=76.5%. Numărul zile de spitalizare:Rockall AUROC 0.66, Se=61.5%, Sp=65.2%,
PPV=90%, NPV=25%;Cedars-Sinai AUROC 0.63, Se=53.1%, Sp=73.9%, PPV=89.5%,
NPV=27.4%;Baylor AUROC 0.52, Se=47.06%, Sp=66.6%, PPV=84.2%, NPV=25%.
Resângerare:Rockall AUROC 0.69, Se=69.1%, Sp=60.4%, PPV=14.2%,
NPV=92.8%;Cedars-Sinai AUROC 0.73, Se=84.4%, Sp=49.02%, PPV=13.7%,
NPV=97%;Baylor AUROC 0.54, Se=35.1%, Sp=81.2%, PPV=16.2%, NPV=92.4%.
Transfer chirurgie:Rockall AUROC 0.67, Se=71.2%, Sp=59%, PPV=16%,
NPV=98.1%;Cedars-Sinai AUROC 0.72, Se=58%, Sp=77.4%, PPV=9.3%,
NPV=97.9%;Baylor AUROC 0.55, Se=50%, Sp=66.2%, PPV=5.1%, NPV=97.4%.
Deces:Rockall AUROC 0.85, Se=84.7%, Sp=76%, PPV=18.2%, NPV=99.5%;Cedars-Sinai
AUROC 0.71, Se=83.1%, Sp=48.1%, PPV=10.2%, NPV=97.6%;Baylor AUROC 0.75,
Se=76.09%, Sp=72.3%, PPV=19.2%, NPV=97.2%. Nu s-au evidenţiat diferenţe semnificative
statistic în prezicerea necesarului de transfuzii şi transferului în chirurgie între
scoruri(p>0.05).Scorul Baylor a fost superior vs. Rockall în estimarea duratei spitalizării
(p=0.04) şi riscului de resângerare (p=0.0009), iar Cedars-Sinai s-a dovedit superior scorului
Baylor în prezicerea resângerării (p=0.002) şi scorului Rockall în prezicerea decesului
(p=0.006). În concluzie, scorul Cedars-Sinai a fost cel mai bun în prezicerea resângerării şi a
decesului la pacienţii cu HDS-NV.
Cuvinte cheie: hemoragie digestivă non-variceală, scoruri de risc, prognostic
COMPARISON OF THE RISK SCORING SYSTEMS USED IN NON-VARICEAL UPPER DIGESTIVE
BLEEDING FOR ASSESSING PATIENT’S PROGNOSIS AND THEIR ACCURACY
Daniela Lazăr1,Ioan Sporea1, Denisia Tornea1, Liliana Girboni1, Cristina Filip1, Virgil Ardelean1, Raluca
Lupuşoru1, Ioan Romoşan2, Adrian Goldiş1
Introduction: The aim of the study consisted in the analysis of the accuracy of three risk scoring
systems used in non-variceal upper digestive bleeding (NV-UDB) for assessing patient’s prognosis,
previously estimated to be predictive for re-bleeding/death after gastrointestinal bleeding.
Material and method: We assessed prospectively a batch of 1872 patients admitted in the
Gastroenterology department of Emergency County Hospital Timisoara in a 12 years period, in which
we calculated 3 risk scoring systems, Rockall, Cedars-Sinai and Baylor. We compared their accuracy
for assessing patient’s prognosis, expressed as the need of blood transfusions, number of
hospitalization days, re-bleeding, surgery and death. Discriminative ability was assessed using the
area under the receiver operating characteristic curve (AUROC).
Results and conclusion: The batch included 1134 (60.6%) male and 738 (39.4%) female, mean age
627.8 years. Regarding the need of blood transfusions, the predictive ability of the scores is as
follows:Rockall AUROC 0.59, sensitivity(Se)=81.7%, specificity(Sp)=35.5%, positive predictive
value(PPV)=28.4%, negative predictive value(NPV)=86.1%;Cedars-Sinai AUROC 0.59, Se=72.4%,
Sp=41.3%, PPV=28.5%, NPV=82.3%;Baylor AUROC 0.56, Se=41.9%, Sp=75.5%, PPV=40.6%,
NPV=76.5%. Number of hospitalization days:Rockall AUROC 0.66, Se=61.5%, Sp=65.2%, PPV=90%,
NPV=25%;Cedars-Sinai AUROC 0.63, Se=53.1%, Sp=73.9%, PPV=89.5%, NPV=27.4%;Baylor AUROC
0.52, Se=47.06%, Sp=66.6%, PPV=84.2%, NPV=25%. Re-bleeding:Rockall AUROC 0.69, Se=69.1%,
Sp=60.4%, PPV=14.2%, NPV=92.8%;Cedars-Sinai AUROC 0.73, Se=84.4%, Sp=49.02%, PPV=13.7%,
NPV=97%;Baylor AUROC 0.54, Se=35.1%, Sp=81.2%, PPV=16.2%, NPV=92.4%. Surgery:Rockall AUROC
0.67, Se=71.2%, Sp=59%, PPV=16%, NPV=98.1%;Cedars-Sinai AUROC 0.72, Se=58%, Sp=77.4%,
PPV=9.3%, NPV=97.9%;Baylor AUROC 0.55, Se=50%, Sp=66.2%, PPV=5.1%, NPV=97.4%.
Death:Rockall AUROC 0.85, Se=84.7%, Sp=76%, PPV=18.2%, NPV=99.5%;Cedars-Sinai AUROC 0.71,
Se=83.1%, Sp=48.1%, PPV=10.2%, NPV=97.6%;Baylor AUROC 0.75, Se=76.09%, Sp=72.3%,
PPV=19.2%, NPV=97.2%. There were no statistically significant differences encountered in predicting
the need of blood transfusions and surgery between the scores(p>0.05). Baylor score was superior vs
Rockall in estimating the hospitalization period (p=0.04) and the risk of re-bleeding (p=0.0009), and
Cedars-Sinai proved to be superior to Baylor score in predicting re-bleeding (p=0.002) and to Rockall
score in predicting death (p=0.006). In conclusion, Cedars-Sinai score was the best in predicting the
re-bleeding and death in patients with NV-UDB.